Cormorant Asset Management as of Sept. 30, 2021
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 88 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Erasca (ERAS) | 8.8 | $217M | 11M | 20.64 | |
| Turning Point Therapeutics I | 7.7 | $189M | 2.8M | 66.43 | |
| Atea Pharmaceuticals (AVIR) | 7.0 | $173M | 4.9M | 35.06 | |
| Forma Therapeutics Hldgs SHS | 4.4 | $110M | 4.7M | 23.19 | |
| Revolution Medicines (RVMD) | 3.5 | $87M | 3.1M | 27.51 | |
| Olema Pharmaceuticals (OLMA) | 3.4 | $85M | 3.1M | 27.56 | |
| Bridgebio Pharma (BBIO) | 3.4 | $83M | 1.8M | 46.87 | |
| Design Therapeutics (DSGN) | 3.2 | $79M | 5.4M | 14.69 | |
| Alx Oncology Hldgs (ALXO) | 3.0 | $75M | 1.0M | 73.86 | |
| Monte Rosa Therapeutics (GLUE) | 2.8 | $68M | 3.1M | 21.91 | |
| Immuneering Corp Class A Com (IMRX) | 2.4 | $59M | 2.3M | 25.95 | |
| Edgewise Therapeutics (EWTX) | 2.3 | $56M | 3.4M | 16.60 | |
| Bioatla (BCAB) | 2.2 | $54M | 1.8M | 29.44 | |
| Avidity Biosciences Ord (RNA) | 2.2 | $53M | 2.2M | 24.63 | |
| Tango Therapeutics (TNGX) | 2.0 | $49M | 3.9M | 12.52 | |
| Prometheus Biosciences | 1.8 | $44M | 1.8M | 23.71 | |
| Aerovate Therapeutics (AVTE) | 1.7 | $42M | 2.0M | 20.66 | |
| Biomea Fusion (BMEA) | 1.5 | $38M | 3.2M | 11.97 | |
| Cytokinetics Com New (CYTK) | 1.5 | $36M | 1.0M | 35.74 | |
| Rain Therapeutics | 1.4 | $35M | 2.3M | 14.96 | |
| Ambrx Biopharma Sponsored Ads | 1.3 | $33M | 2.5M | 13.31 | |
| Verve Therapeutics (VERV) | 1.3 | $33M | 709k | 46.06 | |
| Stoke Therapeutics (STOK) | 1.3 | $33M | 1.3M | 25.44 | |
| Tarsus Pharmaceuticals (TARS) | 1.3 | $31M | 1.4M | 21.55 | |
| Apellis Pharmaceuticals (APLS) | 1.2 | $31M | 925k | 32.96 | |
| Rocket Pharmaceuticals (RCKT) | 1.2 | $29M | 969k | 29.89 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.2 | $29M | 1.7M | 16.63 | |
| Zymeworks | 1.1 | $28M | 950k | 29.04 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.1 | $27M | 170k | 159.39 | |
| Aclaris Therapeutics (ACRS) | 1.1 | $27M | 1.5M | 18.00 | |
| Agenus Com New | 1.0 | $25M | 4.8M | 5.25 | |
| Igm Biosciences (IGMS) | 0.9 | $23M | 350k | 65.76 | |
| Mirati Therapeutics | 0.9 | $21M | 120k | 176.91 | |
| Axonics Modulation Technolog (AXNX) | 0.9 | $21M | 322k | 65.09 | |
| Longboard Pharmaceuticals In (LBPH) | 0.8 | $20M | 2.3M | 8.87 | |
| Cabaletta Bio (CABA) | 0.8 | $20M | 1.6M | 12.16 | |
| Praxis Precision Medicines I | 0.8 | $19M | 1.0M | 18.49 | |
| Tyra Biosciences (TYRA) | 0.7 | $18M | 1.1M | 16.97 | |
| Vectivbio Hldg Ord Shs | 0.7 | $17M | 2.2M | 7.73 | |
| Talaris Therapeutics | 0.7 | $16M | 1.2M | 13.45 | |
| Blueprint Medicines (BPMC) | 0.6 | $15M | 150k | 102.81 | |
| Elevation Oncology (ELEV) | 0.6 | $15M | 2.0M | 7.63 | |
| I Mab Sponsored Ads (IMAB) | 0.6 | $15M | 200k | 72.49 | |
| Y Mabs Therapeutics (YMAB) | 0.6 | $14M | 500k | 28.54 | |
| Akero Therapeutics (AKRO) | 0.5 | $13M | 600k | 22.35 | |
| Gh Research Ordinary Shares (GHRS) | 0.5 | $13M | 608k | 21.62 | |
| Omeros Corporation (OMER) | 0.5 | $13M | 950k | 13.79 | |
| Icosavax | 0.5 | $12M | 426k | 28.70 | |
| Pharvaris N V (PHVS) | 0.5 | $12M | 690k | 17.73 | |
| Connect Biopharma Hldgs Ads (CNTB) | 0.5 | $12M | 500k | 23.90 | |
| Inspire Med Sys (INSP) | 0.5 | $11M | 48k | 232.88 | |
| Anaptysbio Inc Common (ANAB) | 0.4 | $10M | 385k | 27.12 | |
| Aligos Therapeutics (ALGS) | 0.4 | $10M | 667k | 15.51 | |
| Reata Pharmaceuticals Cl A | 0.4 | $10M | 100k | 100.61 | |
| Dermtech Ord ord (DMTKQ) | 0.4 | $9.6M | 300k | 32.11 | |
| Beam Therapeutics (BEAM) | 0.4 | $8.7M | 100k | 87.01 | |
| Travere Therapeutics (TVTX) | 0.3 | $8.5M | 350k | 24.25 | |
| Pliant Therapeutics (PLRX) | 0.3 | $8.1M | 482k | 16.88 | |
| Eledon Pharmaceuticals (ELDN) | 0.3 | $8.1M | 1.3M | 6.18 | |
| Iteos Therapeutics (ITOS) | 0.3 | $7.8M | 288k | 27.00 | |
| Uniqure Nv SHS (QURE) | 0.3 | $7.7M | 240k | 32.01 | |
| Female Health (VERU) | 0.3 | $6.8M | 800k | 8.53 | |
| Myovant Sciences | 0.3 | $6.7M | 300k | 22.44 | |
| Aptose Biosciences Com New | 0.3 | $6.5M | 3.0M | 2.18 | |
| Morphic Hldg (MORF) | 0.2 | $5.7M | 100k | 56.64 | |
| Miragen Therapeutics (VRDN) | 0.2 | $5.6M | 343k | 16.45 | |
| Merus N V (MRUS) | 0.2 | $5.5M | 250k | 22.00 | |
| Deciphera Pharmaceuticals | 0.2 | $4.9M | 144k | 33.98 | |
| Astria Therapeutics (ATXS) | 0.2 | $4.9M | 553k | 8.84 | |
| Akouos | 0.2 | $4.6M | 395k | 11.61 | |
| Renovacor | 0.2 | $4.5M | 500k | 9.05 | |
| Helix Acquisition Corp Com Cl A | 0.2 | $4.3M | 430k | 9.94 | |
| Harpoon Therapeutics | 0.2 | $4.3M | 541k | 7.90 | |
| Galecto (GLTO) | 0.2 | $4.1M | 1.2M | 3.59 | |
| Tcr2 Therapeutics Inc cs | 0.2 | $4.1M | 480k | 8.51 | |
| Precision Biosciences Ord | 0.2 | $4.0M | 347k | 11.54 | |
| Magenta Therapeutics | 0.1 | $3.5M | 478k | 7.28 | |
| Graphite Bio | 0.1 | $3.3M | 203k | 16.06 | |
| Sorrento Therapeutics Com New (SRNE) | 0.1 | $3.1M | 400k | 7.63 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $2.6M | 392k | 6.55 | |
| Gossamer Bio (GOSS) | 0.1 | $2.5M | 198k | 12.57 | |
| Quotient SHS | 0.1 | $2.3M | 1.0M | 2.34 | |
| Atreca Cl A Com (BCEL) | 0.1 | $1.7M | 274k | 6.23 | |
| Orchard Therapeutics Ads | 0.0 | $590k | 257k | 2.30 | |
| X4 Pharmaceuticals (XFOR) | 0.0 | $550k | 104k | 5.29 | |
| Imv | 0.0 | $385k | 234k | 1.64 | |
| Minerva Neurosciences | 0.0 | $167k | 96k | 1.74 | |
| Outlook Therapeutics *w Exp 02/18/202 | 0.0 | $54k | 271k | 0.20 |
